A Totally Implantable Drug Infusion Defice: Laboratory and Clinical Experience Using a Model with Single Flow Rate and New Design for Modulated Insulin Infusion

The Infusaid implantable infusion pump with a single delivery rate has maintained chronic intravenous heparin infusion in man for greater than 35 mo and for greater than 5 yr in the dog. Intra-arterial infuson of fluorodeoxyuridine has been maintained for greater than 8 mo in man. In a pilot study using a commercially available, transcutaneously controllable, magnetically activated valve for baseline superimposed bolus insulin infusion, the feasibility of maintaining near normal serum glucose in diabetic dogs was demonstrated. The effect of long-term intravenous cannulation was investigated; it was found that the intimal tissues of the vena cava surrounding the cannulae were largely unaltered and microemboli could not be detected in the lungs of the animals studied. Cannula plugging, which occurred on several occasions due to thrombus formation in the final centimeter of the cannula, has been solved by changes in pump design and refilling procedures. The problem of insulin precipitation in flow passages of the pump remains unsolved, but there are indications that substances entering the cannula from the blood may be involved. A new pump design for modulated insulin infusion is described.

[1]  P. Blackshear,et al.  A permanently implantable self-recycling low flow constant rate multipurpose infusion pump of simple design. , 1970, Surgical forum.

[2]  H Buchwald,et al.  The design and initial testing of an implantable infusion pump. , 1972, Surgery, gynecology & obstetrics.

[3]  G. Slama,et al.  One to Five Days of Continuous Intravenous Insulin Infusion on Seven Diabetic Patients , 1974, Diabetes.

[4]  R. Varco,et al.  Chronic heparin anticoagulant in dogs by continuous infusion with a totally implantable pump. , 1975, Transactions - American Society for Artificial Internal Organs.

[5]  P. Blackshear,et al.  One year of continuous heparinization in the dog using a totally implantable infusion pump. , 1975, Surgery, gynecology & obstetrics.

[6]  P. Blackshear,et al.  PROTRACTED PARENTERAL DRUG INFUSION IN AMBULATORY SUBJECTS USING AN IMPLANTABLE INFUSION PUMP , 1977, Transactions - American Society for Artificial Internal Organs.

[7]  P. Blackshear,et al.  One year of heparin anticoagulation. An ambulatory subject using a totally implantable infusion pump. , 1977, Minnesota medicine.

[8]  S. Genuth,et al.  Control of Hyperglycemia in Adult Diabetics by Pulsed Insulin Delivery , 1977, Diabetes.

[9]  P. Blackshear,et al.  Design and initial testing of a totally implantable transcutaneously controllable insulin delivery device. , 1978, Transactions - American Society for Artificial Internal Organs.

[10]  F. Service.  Normalization of plasma glucose of unstable diabetes: studies under ambulatory, fed conditions with pumped intravenous insulin. , 1978, The Journal of laboratory and clinical medicine.

[11]  H Keen,et al.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. , 1978, British medical journal.

[12]  K. Irsigler,et al.  Long-Term Continuous Intravenous Insulin Therapy with a Portable Insulin Dosage-regulating Apparatus , 1979, Diabetes.

[13]  W. Tamborlane,et al.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.

[14]  P. Blackshear,et al.  Control of Blood Glucose in Experimental Diabetes by Means of a Totally Implantable Insulin Infusion Device , 1979, Diabetes.

[15]  P. Blackshear,et al.  Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump , 1980, Cancer.